Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

RSV Vaccine in Transplant Recipients — Stella

Home/Vaccine Response Impaired/RSV Vaccine in Transplant Recipients

View on ClinicalTrials.gov

Recruiting

Back to Vaccine Response Impaired trials

RSV Vaccine in Transplant Recipients

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(1 site)

Canada

University Health Network, Toronto

Key details

Phase

Large-scale testing

Sponsor

University Health Network, Toronto

Collaborators

The PSI Foundation, Ontario, University of British Columbia

Enrollment target

~100 participants

Started

October 2024

Primary completion

March 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated November 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.